-
-
公开(公告)号：HK1186479A1
公开(公告)日：2014-03-14
申请号：HK13113804
申请日：2013-12-12
Applicant: UCB PHARMA SA
IPC: C07K20060101 , C07K16/18 , A61K38/16 , A61K39/395 , A61P35/00 , C07K16/28 , C12N15/13 , C12N15/63 , C12P21/00
-
公开(公告)号：ES2351208T3
公开(公告)日：2011-02-01
申请号：ES02800666
申请日：2002-10-10
Applicant: UCB PHARMA SA
Inventor： POPPLEWELL ANDREW GEORGE , TICKLE SIMON PETER , MORRISON ROBERT KENDALL , ZINKEWICH-PEOTTI KAREN
IPC: C07K16/28 , C12N15/09 , A61K39/395 , A61K47/48 , A61P17/00 , A61P17/06 , A61P19/02 , A61P29/00 , A61P35/00 , A61P35/04 , A61P37/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/13 , C12P21/02 , C12P21/08
Abstract: Una molécula de anticuerpo que tiene especificidad para KDR humano, que comprende una región variable de la cadena pesada del SEQ ID NO: 15 y una región variable de la cadena ligera del SEQ ID NO: 16.
-
公开(公告)号：AU2003223007B2
公开(公告)日：2009-07-16
申请号：AU2003223007
申请日：2003-05-02
Applicant: UCB PHARMA SA
Abstract: There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing CD22.
-
公开(公告)号：AU2005305677A1
公开(公告)日：2006-05-26
申请号：AU2005305677
申请日：2005-11-16
Applicant: UCB PHARMA SA
Inventor： ADAMS RALPH , RAPECKI STEPHEN EDWARD , TICKLE SIMON PETER , POPPLEWELL ANDREW GEORGE
Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
-
Patent Agency Ranking
-
公开(公告)号：ME01810B
公开(公告)日：2014-09-20
申请号：MEP3314
申请日：2005-11-16
Applicant: UCB PHARMA SA
Inventor： ADAMS RALPH , POPPLEWELL ANDREW GEORGE , RAPECKI STEPHEN EDWARD , TICKLE SIMON PETER
-
公开(公告)号：ES2456669T3
公开(公告)日：2014-04-23
申请号：ES05803526
申请日：2005-11-16
Applicant: UCB PHARMA SA
Inventor： ADAMS RALPH , POPPLEWELL ANDREW GEORGE , RAPECKI STEPHEN EDWARD , TICKLE SIMON PETER
Abstract: Un anticuerpo neutralizante que tiene especificidad para IL-17 humana, con una cadena pesada que comprende la secuencia gH11 (SEC ID Nº: 11) y una cadena ligera que comprende la secuencia gL3 (SEC ID Nº: 13).
-
公开(公告)号：AU2005305677B2
公开(公告)日：2012-02-02
申请号：AU2005305677
申请日：2005-11-16
Applicant: UCB PHARMA SA
Inventor： ADAMS RALPH , RAPECKI STEPHEN EDWARD , TICKLE SIMON PETER , POPPLEWELL ANDREW GEORGE
Abstract: The invention relates to an antibody molecule having specificity for antigenic determinants of IL- 17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule.
-
公开(公告)号：PL208848B1
公开(公告)日：2011-06-30
申请号：PL37034402
申请日：2002-10-10
Applicant: UCB PHARMA SA
-
-
-
-
-
-
-
-
-
Search Results
43
records
(took 0.022 seconds)
